VPS25 Activators
The class of chemicals referred to as VPS25 Activators comprises compounds that primarily influence the processes of endocytosis, endosomaltrafficking, and multivesicular body (MVB) biogenesis. These compounds modulate various cellular pathways that indirectly affect the function of VPS25 due to its integral role in the ESCRT-II complex, which is pivotal for MVB formation and endosomal cargo sorting. VPS25 Activators disrupt the acidic environment within endosomes or interfere with ion balance, affecting cargo sorting and potentially influencing VPS25 function. Similarly, activators disrupt intracellular cholesterol trafficking, which can also influence cargo sorting and VPS25. they can also modulate endocytosis and cellular growth, respectively, both of which indirectly enhance endosomal trafficking and potentially VPS25 function.
VPS25 Activators impact VPS25 activity via the disruption of actin dynamics or inhibition of myosin light chain kinase, respectively, both of which regulate endosomal trafficking. Furthermore, activators can affect the function of the ESCRT-II complex, including VPS25, by inhibiting PI3K, a key regulator of endocytosis. Activators can potentially affect ESCRT-II complex function by influencing cellular signaling associated with endocytosis and endosomal trafficking. Lastly, activators, by inhibiting protein biosynthesis, can affect cellular processes including endocytosis and endosomal trafficking, potentially influencing VPS25 function.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Monensin A | 17090-79-8 | sc-362032 sc-362032A | 5 mg 25 mg | $155.00 $525.00 | ||
Monensin is an ionophore antibiotic which disrupts endosomal trafficking by altering the ion balance. This disruption can influence the sorting of cargos and the function of the ESCRT-II complex, including VPS25. | ||||||
Dynamin Inhibitor I, Dynasore | 304448-55-3 | sc-202592 | 10 mg | $89.00 | 44 | |
Dynasore is a cell-permeable inhibitor of the GTPase activity of dynamin. Dynamin is involved in endocytosis and by inhibiting dynamin, endocytic pathway is affected, potentially influencing the sorting of cargos and the function of the ESCRT-II complex, including VPS25. | ||||||
MHY1485 | 326914-06-1 | sc-507522 | 10 mg | $140.00 | ||
MHY1485 is a potent activator of mTOR, a regulator of cell growth and proliferation. Activation of mTOR can stimulate cellular growth and proliferation, which indirectly enhances endosomal trafficking and potentially the activity of the ESCRT-II complex, including VPS25. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and specific inhibitor of phosphoinositide 3-kinases (PI3K). PI3K plays a role in the regulation of endocytosis and endosomal trafficking. Therefore, by inhibiting PI3K, wortmannin can influence ESCRT-II complex function, including VPS25. | ||||||
ML-9 | 105637-50-1 | sc-200519 sc-200519A sc-200519B sc-200519C | 10 mg 50 mg 100 mg 250 mg | $112.00 $449.00 $673.00 $1224.00 | 2 | |
ML-9 is an inhibitor of myosin light chain kinase (MLCK). MLCK is involved in actin-myosin contractility which is needed for certain steps in endocytosis and endosomal trafficking. By inhibiting MLCK, ML-9 can influence the function of the ESCRT-II complex, including VPS25. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine is a weak base that accumulates in acidic vesicles such as endosomes and lysosomes, disrupting their functions. This can influence the sorting of cargos and the function of the ESCRT-II complex, including VPS25. | ||||||
Genistein | 446-72-0 | sc-3515 sc-3515A sc-3515B sc-3515C sc-3515D sc-3515E sc-3515F | 100 mg 500 mg 1 g 5 g 10 g 25 g 100 g | $45.00 $164.00 $200.00 $402.00 $575.00 $981.00 $2031.00 | 46 | |
Genistein is a broad-spectrum tyrosine kinase inhibitor. Tyrosine kinases play roles in cellular signaling that can influence endocytosis and endosomal trafficking, thus potentially affecting the function of the ESCRT-II complex, including VPS25. | ||||||
Cycloheximide | 66-81-9 | sc-3508B sc-3508 sc-3508A | 100 mg 1 g 5 g | $41.00 $84.00 $275.00 | 127 | |
Cycloheximide is an inhibitor of protein biosynthesis in eukaryotes. By inhibiting protein biosynthesis, cycloheximide can affect cellular processes including endocytosis and endosomal trafficking, potentially influencing the function of the ESCRT-II complex, including VPS25. | ||||||